Scienture secures GPO deals for naloxone nasal spray
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Scienture Holdings Inc (SCNX)
Assess today's live Scienture Holdings Inc (SCNX) share price, performance and insights using our live NASDAQ: SCNX stock exchange data.
Analyse the historical data and Scienture Holdings Inc share price performance charts on this page. Our technical summary section provides analysis on Scienture Holdings share price buy/sell indicators using real-time data (or discuss the Scienture Holdings (SCNX) stock price today with other investors in the Scienture Holdings NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SCNX share price (ISIN: US80880X1046) to enhance your trading decisions with our free investment tools and resources.
What Is the Scienture Holdings Inc Share Price Today?
The Scienture Holdings share price today is 0.389.
What Is the Stock Symbol for Scienture Holdings Inc
The stock symbol (or 'ticker') for Scienture Holdings Inc is "SCNX."
What Stock Exchange Does Scienture Holdings Inc Trade On?
Scienture Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Scienture Holdings Inc a Good Stock to Buy?
Determining whether Scienture Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Scienture Holdings Inc share price performance charts on this page. Our technical summary section provides analysis on Scienture Holdings share price buy/sell indicators using real-time data (or discuss the Scienture Holdings (SCNX) stock price today with other investors in the Scienture Holdings NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ SCNX share price (ISIN: US80880X1046) to enhance your trading decisions with our free investment tools and resources.
What Is the Scienture Holdings Inc Share Price Today?
The Scienture Holdings share price today is 0.389.
What Is the Stock Symbol for Scienture Holdings Inc
The stock symbol (or 'ticker') for Scienture Holdings Inc is "SCNX."
What Stock Exchange Does Scienture Holdings Inc Trade On?
Scienture Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Scienture Holdings Inc a Good Stock to Buy?
Determining whether Scienture Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.387
0.400
52 wk Range
0.372
3.170
Unusual Pre-Market activity
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3870.400
52 wk Range
0.3723.170
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SCNX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
1.500
Upside
+285.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
- Trxade receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Scienture secures GPO deals for naloxone nasal spray
- Investing.com
- Trxade receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company operates through Integra and Scienture segments. The Integra segment engages in the wholesale and sale of licensed pharmaceutical brand, generic, and non-drug products. The Scienture segment researches and develops branded pharmaceutical products. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is based in Tampa, Florida.
Compare SCNX to Peers and Sector
Metrics to compare | SCNX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSCNXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −0.5x | −0.5x | |
PEG Ratio | 0.01 | 0.07 | 0.00 | |
Price/Book | 0.2x | 0.8x | 2.6x | |
Price / LTM Sales | 24.2x | 0.7x | 3.2x | |
Upside (Analyst Target) | 284.6% | 116.6% | 50.1% | |
Fair Value Upside | Unlock | 45.6% | 6.5% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1.500
(+285.60% Upside)
Earnings
Latest Release
Nov 12, 2025
EPS / Forecast
-0.19 / --
Revenue / Forecast
590.05K / --
People Also Watch
FAQ
What Is the Scienture Holdings (SCNX) Share Price Today?
The Scienture Holdings stock price today is 0.389 USD.
What Stock Exchange Does Scienture Holdings (SCNX) Trade On?
Scienture Holdings is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Scienture Holdings?
The stock symbol (also called a 'ticker') for Scienture Holdings is "SCNX."
What Is the Current Scienture Holdings Market Cap?
As of today, Scienture Holdings market cap is 15.790M USD.
What Is Scienture Holdings's (SCNX) Earnings Per Share (TTM)?
The Scienture Holdings EPS is currently -1.572 (Trailing Twelve Months).
Is SCNX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Scienture Holdings moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Scienture Holdings Stock Split?
Scienture Holdings has split 4 times. (See the SCNX stock split history page for full effective split date and price information.)
How Many Employees Does Scienture Holdings Have?
Scienture Holdings has 17 employees.
What is the current trading status of Scienture Holdings (SCNX)?
As of 11/03/2026, Scienture Holdings (SCNX) is trading at a price of 0.389 USD, with a previous close of 0.389 USD. The stock has fluctuated within a day range of 0.387 USD to 0.400 USD, while its 52-week range spans from 0.372 USD to 3.170 USD.
What Is Scienture Holdings (SCNX) Price Target According to Analysts?
The average 12-month price target for Scienture Holdings is 1.500 USD, with a high estimate of 1.5 USD and a low estimate of 1.5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +285.60% Upside potential.
What Is the SCNX Premarket Price?
SCNX's last pre-market stock price is 0.555 USD. The pre-market share volume is 45,410,000.000, and the stock has decreased by 0.167, or 42.960%.
What Is the SCNX After Hours Price?
SCNX's last after hours stock price is 0.408 USD, the stock has decreased by 0.019, or 4.880%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.